168 related articles for article (PubMed ID: 33577812)
1. Sustained release of epigallocatechin-3-gallate from chitosan-based scaffolds to promote osteogenesis of mesenchymal stem cell.
Wang J; Sun Q; Wei Y; Hao M; Tan WS; Cai H
Int J Biol Macromol; 2021 Apr; 176():96-105. PubMed ID: 33577812
[TBL] [Abstract][Full Text] [Related]
2. The chitosan/carboxymethyl cellulose/montmorillonite scaffolds incorporated with epigallocatechin-3-gallate-loaded chitosan microspheres for promoting osteogenesis of human umbilical cord-derived mesenchymal stem cell.
Wang J; He W; Tan WS; Cai H
Bioresour Bioprocess; 2022 Apr; 9(1):36. PubMed ID: 38647806
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-modified chitosan-agarose-gelatin scaffold for sustained release of SDF-1 and BMP-2.
Wang B; Guo Y; Chen X; Zeng C; Hu Q; Yin W; Li W; Xie H; Zhang B; Huang X; Yu F
Int J Nanomedicine; 2018; 13():7395-7408. PubMed ID: 30519022
[TBL] [Abstract][Full Text] [Related]
4. Alginate/Gelatin scaffolds incorporated with Silibinin-loaded Chitosan nanoparticles for bone formation in vitro.
Leena RS; Vairamani M; Selvamurugan N
Colloids Surf B Biointerfaces; 2017 Oct; 158():308-318. PubMed ID: 28711017
[TBL] [Abstract][Full Text] [Related]
5. Regulating Preparation Of Functional Alginate-Chitosan Three-Dimensional Scaffold For Skin Tissue Engineering.
Zhu T; Jiang J; Zhao J; Chen S; Yan X
Int J Nanomedicine; 2019; 14():8891-8903. PubMed ID: 32009786
[TBL] [Abstract][Full Text] [Related]
6. Poly-l-lactic acid scaffold incorporated chitosan-coated mesoporous silica nanoparticles as pH-sensitive composite for enhanced osteogenic differentiation of human adipose tissue stem cells by dexamethasone delivery.
Porgham Daryasari M; Dusti Telgerd M; Hossein Karami M; Zandi-Karimi A; Akbarijavar H; Khoobi M; Seyedjafari E; Birhanu G; Khosravian P; SadatMahdavi F
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4020-4029. PubMed ID: 31595797
[TBL] [Abstract][Full Text] [Related]
7. Bioactive peptides/chitosan nanoparticles enhance cellular antioxidant activity of (-)-epigallocatechin-3-gallate.
Hu B; Ting Y; Zeng X; Huang Q
J Agric Food Chem; 2013 Jan; 61(4):875-81. PubMed ID: 23293838
[TBL] [Abstract][Full Text] [Related]
8. Investigating the mechanical, physiochemical and osteogenic properties in gelatin-chitosan-bioactive nanoceramic composite scaffolds for bone tissue regeneration: In vitro and in vivo.
Dasgupta S; Maji K; Nandi SK
Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():713-728. PubMed ID: 30423758
[TBL] [Abstract][Full Text] [Related]
9. Study of bone repair mediated by recombination BMP-2/ recombination CXC chemokine Ligand-13-loaded hollow hydroxyapatite microspheres/chitosan composite.
Zeng J; Xiong S; Ding L; Zhou J; Li J; Qiu P; Liao X; Xiong L; Long Z; Liu S
Life Sci; 2019 Oct; 234():116743. PubMed ID: 31408660
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate protects against tumor necrosis factor alpha induced inhibition of osteogenesis of mesenchymal stem cells.
Liu W; Fan JB; Xu DW; Zhang J; Cui ZM
Exp Biol Med (Maywood); 2016 Mar; 241(6):658-66. PubMed ID: 26748399
[TBL] [Abstract][Full Text] [Related]
11. Homologous Sodium Alginate/Chitosan-Based Scaffolds, but Contrasting Effect on Stem Cell Shape and Osteogenesis.
Zhang L; Fang H; Zhang K; Yin J
ACS Appl Mater Interfaces; 2018 Feb; 10(8):6930-6941. PubMed ID: 29392929
[TBL] [Abstract][Full Text] [Related]
12. Porous chitosan derivative scaffolds affect proliferation and osteogenesis of mesenchymal stem cell via reducing intracellular ROS.
Wang J; Zhou L; Sun Q; Cai H; Tan WS
Carbohydr Polym; 2020 Jun; 237():116108. PubMed ID: 32241448
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro study.
Jin P; Wu H; Xu G; Zheng L; Zhao J
Cell Tissue Res; 2014 May; 356(2):381-90. PubMed ID: 24682582
[TBL] [Abstract][Full Text] [Related]
14. Novel biomimetic tripolymer scaffolds consisting of chitosan, collagen type 1, and hyaluronic acid for bone marrow-derived human mesenchymal stem cells-based bone tissue engineering.
Mathews S; Bhonde R; Gupta PK; Totey S
J Biomed Mater Res B Appl Biomater; 2014 Nov; 102(8):1825-34. PubMed ID: 24723571
[TBL] [Abstract][Full Text] [Related]
15. Assessment of human ovarian follicular fluid derived mesenchymal stem cells in chitosan/PCL/Zn scaffold for bone tissue regeneration.
Chandramohan Y; Jeganathan K; Sivanesan S; Koka P; Amritha TMS; Vimalraj S; Dhanasekaran A
Life Sci; 2021 Jan; 264():118502. PubMed ID: 33031825
[TBL] [Abstract][Full Text] [Related]
16. Embedded silica nanoparticles in poly(caprolactone) nanofibrous scaffolds enhanced osteogenic potential for bone tissue engineering.
Ganesh N; Jayakumar R; Koyakutty M; Mony U; Nair SV
Tissue Eng Part A; 2012 Sep; 18(17-18):1867-81. PubMed ID: 22725098
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and releasing property of antibacterial nano-capsules composed of ε-PL-EGCG and sodium alginate-chitosan.
Li W; Li W; Wan Y; Wang L; Zhou T
Int J Biol Macromol; 2022 Apr; 204():652-660. PubMed ID: 35093440
[TBL] [Abstract][Full Text] [Related]
18. Strontium hydroxyapatite/chitosan nanohybrid scaffolds with enhanced osteoinductivity for bone tissue engineering.
Lei Y; Xu Z; Ke Q; Yin W; Chen Y; Zhang C; Guo Y
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():134-142. PubMed ID: 28024569
[TBL] [Abstract][Full Text] [Related]
19. Fabrication and characterization of Chrysin - A plant polyphenol loaded alginate -chitosan composite for wound healing application.
Kaparekar PS; Poddar N; Anandasadagopan SK
Colloids Surf B Biointerfaces; 2021 Oct; 206():111922. PubMed ID: 34157519
[TBL] [Abstract][Full Text] [Related]
20. Understanding the molecular mechanism of improved proliferation and osteogenic potential of human mesenchymal stem cells grown on a polyelectrolyte complex derived from non-mulberry silk fibroin and chitosan.
Bissoyi A; Kumar Singh A; Kumar Pattanayak S; Bit A; Kumar Sinha S; Patel A; Jain V; Kumar Patra P
Biomed Mater; 2017 Dec; 13(1):015011. PubMed ID: 29216011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
